Results 31 to 40 of about 5,794,985 (290)

Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems

open access: yesPharmaceuticals, 2010
The successful clinical application of nucleic acid-based therapeutic strategies has been limited by the poor delivery efficiency achieved by existing vectors. The development of alternative delivery systems for improved biological activity is, therefore,
Sara Trabulo   +3 more
doaj   +1 more source

A Synthetic Cell-Penetrating Peptide Antagonizing TrkA Function Suppresses Neuropathic Pain in Mice

open access: yesJournal of Pharmacological Sciences, 2010
Nerve growth factor (NGF) and its high-affinity receptor, TrkA, are one of the targets in the production of new drugs for the treatment of neuropathic pain.
Wei-Ying Ma   +7 more
doaj   +1 more source

Arginine‐rich cell‐penetrating peptides [PDF]

open access: yesFEBS Letters, 2009
Arginine‐rich cell‐penetrating peptides are short cationic peptides capable of traversing the plasma membranes of eukaryotic cells. While successful intracellular delivery of many biologically active macromolecules has been accomplished using these peptides, their mechanisms of cell entry are still under investigation. Recent dialogue has centered on a
Schmidt, Nathan   +3 more
openaire   +2 more sources

Novel Cell-Penetrating Peptide Conjugated Proteasome Inhibitors: Anticancer and Antifungal Investigations. [PDF]

open access: yes, 2019
Cell-penetrating peptide conjugated peptide aldehydes Tat-A and Tat-B showed low micromolar anticancer and antifungal activities and synergistic action in combination with cisplatin and amphotericin B against cancer and fungal cells, respectively.
Reynisson
core   +1 more source

Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis

open access: yesJCI Insight, 2021
To date, there are no inhibitors that directly and specifically target activated STAT3 and c-Myc in the clinic. Although peptide-based inhibitors can selectively block activated targets, their clinical usage is limited because of low cell penetration and/
Maryam Aftabizadeh   +11 more
doaj   +1 more source

Uptake of cell‐penetrating peptides in yeasts [PDF]

open access: yesFEBS Letters, 2005
The uptake of different cell‐penetrating peptides (CPPs) in two yeast species, Saccharomyces cerevisiae and Candida albicans, was studied using fluorescence HPLC‐analyses of cell content. Comparison of the ability of penetratin, pVEC and (KFF)3K to traverse the yeast cell envelope shows that the cellular uptake of the peptides varies widely.
Holm, Tina   +4 more
openaire   +2 more sources

Cell penetrating peptide modified M2 macrophage derived exosomes treat spinal cord injury and rheumatoid arthritis by loading curcumin

open access: yesMaterials & Design, 2023
Effectively suppressing the hyperactivated inflammatory response is a critical strategy for treating inflammatory diseases, such as spinal cord injury (SCI) and rheumatoid arthritis (RA).
Zhuo Li   +9 more
doaj   +1 more source

Non-metabolic membrane tubulation and permeability induced by bioactive peptides. [PDF]

open access: yesPLoS ONE, 2007
BACKGROUND:Basic cell-penetrating peptides are potential vectors for therapeutic molecules and display antimicrobial activity. The peptide-membrane contact is the first step of the sequential processes leading to peptide internalization and cell activity.
Antonin Lamazière   +5 more
doaj   +1 more source

Constrained cell penetrating peptides

open access: yesDrug Discovery Today: Technologies, 2017
In this review we provide an overview of recent developments in the field of cell penetrating peptides (CPPs) on research that aims to achieve better control over their transduction properties - one of the big challenges - by means of restraining them.
S A, Bode, D W P M, Löwik
openaire   +2 more sources

Peptide-based delivery of therapeutics in cancer treatment

open access: yesMaterials Today Bio, 2022
Current delivery strategies for cancer therapeutics commonly cause significant systemic side effects due to required high doses of therapeutic, inefficient cellular uptake of drug, and poor cell selectivity.
Timothy Samec   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy